Not seeing anything here that looks better than Opdivo. Looks like second line is pretty much BMY's market at this point, won't be surprised if the same thing happens with first line.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.